Latest Clinical trial Stories
Focus on the Completion of Phase 3 Clinical Trials and Commercial Preparations for Telotristat Etiprate in Carcinoid Syndrome THE WOODLANDS, Texas, Nov.
LONDON and SUNNYVALE, Calif., Nov. 4, 2014 /PRNewswire/ -- AstraZeneca and Pharmacyclics, Inc.
- Final results from binimetinib Phase 2 in NRAS melanoma confirmed prior Progression Free Survival result and demonstrated encouraging Overall Survival- BOULDER, Colo., Nov.
SOUTH SAN FRANCISCO, Calif., Nov. 4, 2014 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
PLYMOUTH MEETING, Pa., Nov. 4, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc.
NBI-98854 Phase III Program Underway for Tardive Dyskinesia SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
Velos recently activated its Investigational Drug System at The University of Texas MD Anderson Cancer Center FREMONT, Calif., Nov.
MONTREAL, Oct. 31, 2014 /CNW Telbec/ - JSS Medical Research Inc. is pleased to announce that founder and CEO Dr. John S.
Conference Call Scheduled for Monday, November 3, 2014 at 10:00 a.m. Eastern time JERUSALEM, October 31, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.